Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,417 public trials 1,032 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML

NCT06737523

Conditions: Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +11 more
Locations: The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients

NCT06651866

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

NCT06788639

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations: Center for International Blood and Marrow Transplant Research (CIBMTR) Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

NCT06088888

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: The University of Texas MD Anderson Cancer Center Houston, Texas, United States

Fred Hutchinson Cancer Center Seattle, Washington, United States

View Trial Details

Recruiting

TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients

NCT06453902

Conditions: Accelerated Phase CML, Bone Marrow Diseases, Chronic Disease, +13 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML

NCT06827899

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT05603884

Conditions: AML Stage, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

NCT06834529

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations: the Fifth Medical Center of Chinese People's Liberation Army General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies

NCT05991908

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

Zhongshan Hospital, Xianmen University Xiamen, Fujian, China

923th Hospital PLA Nanning, Guangxi, China

First Affiliated Hospital of Nanjin Medical Unviersity Nanjin, Jiangsu, China

View Trial Details

Recruiting

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

NCT06559345

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Leukemia

Leukemia trial results

Related conditions